Scrip Symbol
CIPLA EQ (NSE)
Nature of the Event
Regulatory disclosure regarding the outcome of a US Food and Drug Administration (USFDA) inspection.
Key Details
The USFDA, via a communication dated 10th June 2026 (received at 2217 hours IST), has classified the inspection as Voluntary Action Indicated (VAI).
Prepared and Signed By
The disclosure was prepared by Chirag Hotchandani and signed by Rajendra Chopra, Company Secretary, on 11th June 2026 at 13:46:43 IST.